Showing results (1-10 of 20) with videos related to
Sort By:
Pageof 2
Methods in Molecular Biology (Clifton, N.J.)|November 23, 2020
Generation of Human iPSCs by Episomal Reprogramming of Skin Fibroblasts and Peripheral Blood Mononuclear CellsFabia Febbraro, Muwan Chen, Mark DenhamPlos One|June 17, 2017
Neuronal substrates underlying stress resilience and susceptibility in ratsFabia Febbraro, Katrine Svenningsen, Thao Phuong Tran, et al.Plos One|January 26, 2010
Microglia acquire distinct activation profiles depending on the degree of alpha-synuclein neuropathology in a rAAV based model of Parkinson's diseaseVanesa Sanchez-Guajardo, Fabia Febbraro, Deniz Kirik, et al.Neuroreport|May 15, 2012
α-Synuclein expression is modulated at the translational level by ironFabia Febbraro, Marcello Giorgi, Sara Caldarola, et al.The European Journal of Neuroscience|August 14, 2010
Co-expression of C-terminal truncated alpha-synuclein enhances full-length alpha-synuclein-induced pathologyAyse Ulusoy, Fabia Febbraro, Poul H Jensen, et al.Frontiers in Cell and Developmental Biology|October 16, 2023
Spatially and temporally distinct patterns of expression for VPS10P domain receptors in human cerebral organoidsFabia Febbraro, Helena Hørdum Breum Andersen, Meagan M Kitt, et al.Experimental Neurology|March 28, 2013
Chronic intranasal deferoxamine ameliorates motor defects and pathology in the α-synuclein rAAV Parkinson's modelFabia Febbraro, Kathrine J Andersen, Vanesa Sanchez-Guajardo, et al.Stem Cell Research|December 2, 2019
Generation of eight human induced pluripotent stem cell lines from Parkinson's disease patients carrying familial mutationsMuwan Chen, Muyesier Maimaitili, Susanne Hvolbøl Buchholdt, et al.Stem Cell Research|April 20, 2020
Generation of an induced pluripotent stem cell line (DANi-011A) from a Parkinson's disease patient with a LRRK2 p.G2019S mutationMuwan Chen, Muyesier Maimaitili, Susanne Hvolbøl Buchholdt, et al.Neurobiology of Disease|April 10, 2013
Ser129D mutant alpha-synuclein induces earlier motor dysfunction while S129A results in distinctive pathology in a rat model of Parkinson's diseaseFabia Febbraro, Gurdal Sahin, Aina Farran, et al.Pageof 2